Literature DB >> 20339736

Low frequency of bipolar disorder, dopamine dysregulation syndrome, and punding in Brazilian patients with Parkinson's disease.

Arthur Kummer1, Fernando M V Dias, Francisco Cardoso, Antonio L Teixeira.   

Abstract

OBJECTIVE: To investigate the frequency of bipolar disorder, dopamine dysregulation syndrome and punding in Parkinson's disease patients from a Brazilian movement disorders clinic.
METHOD: One hundred patients underwent a comprehensive psychiatric examination composed of MINI-plus and specific questionnaires to investigate dopamine dysregulation syndrome and punding.
RESULTS: We identified, respectively, one and five Parkinson's disease patients with bipolar disorder type I and type II. All manic/hypomanic episodes occurred before Parkinson's disease onset. No patient was identified with dopamine dysregulation syndrome or punding.
CONCLUSION: The frequency of manic/hypomanic episodes seems to decrease with Parkinson's disease onset, and local environmental factors (e.g. drug availability) may be responsible for the low frequency of dopamine dysregulation syndrome and punding in Brazilian Parkinson's disease patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339736     DOI: 10.1590/s1516-44462010000100012

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  3 in total

1.  Bipolar affective disorder and Parkinson's disease.

Authors:  Birk Engmann
Journal:  Case Rep Med       Date:  2011-11-28

2.  Bipolar disorder, a precursor of Parkinson's disease?

Authors:  Tânia M S Novaretti; Nathália Novaretti; Vitor Tumas
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

3.  Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.

Authors:  Marco Onofrj; Angelo Di Iorio; Claudia Carrarini; Mirella Russo; Raffaella Franciotti; Alberto J Espay; Laura S Boylan; John-Paul Taylor; Massimo Di Giannantonio; Giovanni Martinotti; Enza M Valente; Astrid Thomas; Laura Bonanni; Stefano Delli Pizzi; Fedele Dono; StefanoL Sensi
Journal:  Mov Disord       Date:  2021-08-24       Impact factor: 9.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.